1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > Protein Crystallization & Crystallography Market by Technology (Ion-Exchange Chromatography, HPLC, Gel-Electrophoresis, NMR, X-Ray Crystallography), Products (Reagents & Instruments) & End-Users (Pharmaceutical & Biotechnology Companies) -Forecast to 2018

Protein Crystallization & Crystallography Market by Technology (Ion-Exchange Chromatography, HPLC, Gel-Electrophoresis, NMR, X-Ray Crystallography), Products (Reagents & Instruments) & End-Users (Pharmaceutical & Biotechnology Companies) -Forecast to 2018

Increase in Government-funded Research and Continued Funding by the PSI Ensure Continued Development of New Technologies
Protein crystallization & crystallography are techniques that are used very frequently by researchers to understand the three-dimensional structure of a protein. The market for protein crystallization & crystallography is expected to grow at a high rate owing to its huge potential in drug discovery and development.

This research report categorizes the protein crystallization & crystallography market on the basis of technologies (protein purification, protein crystallization, protein crystal mounting, and protein crystallography), products (analyzers and reagents), and end users (pharmaceutical companies, biotechnology companies, government institutes, and academic institutions). On the basis of technology, the protein crystallization segment accounted for the largest share–47%–of the market in 2013. The growing need to identify new ligands for the drug discovery process and the rising popularity of structure-based/rational drug design are factors that present opportunities for the protein crystallization & crystallography market. The large numbers of ongoing research projects involving protein crystallization, and the increased variety of reagents and analytical techniques employed are are also major drivers for the protein crystallography reagents market. However, low customer loyalty and company-specific reagents are factors that restrict the growth of this market.

Geographically, North America commanded the largest market share of the protein crystallization & crystallography market, followed by Europe. The availability of government and private funds, technological advancements, and growing research in the field of structure-based drug design are factors that are driving the market in these regions. However, the economic downturn and cuts in healthcare budgets are hampering the growth of the market. Countries like China and India will be the major contributors of growth for this market. Increasing investments by leading companies in these immature markets, and increase in research and development activities in these regions are driving the growth.

The deviations and overlap of revenues between the various segments of technology and products in number of sources were the major challenges faced while estimating the market size. They were overcome by the validating the data by a large number of industry experts and key opinion leaders.

From an insight perspective, this research report focuses on various qualitative aspects such as —industry, technology & trends, and company profiles, which together comprises the basic views on the competitive landscape, government initiative, drivers, restraints and opportunities, and key players in the protein crystallization & crystallography market .It also looks at the product portfolio, developments, and strategies to maintain and increase the market share in the near future. The report also concentrates on quantitative analyses like market share analysis, emerging and high growth segments of crystallization & crystallography (chromatography & X-ray crystallography), among others.

The market research data, current market size, and forecast of future trends mentioned above will help the key players and new entrants in the markets to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, R&D investment for innovation in products & technologies, and levels of output in order to remain successful.

Table Of Contents

Protein Crystallization and Crystallography Market by Technology (Ion-Exchange Chromatography, HPLC, Gel-Electrophoresis, NMR, X-Ray Crystallography), Products (Reagents and Instruments) and End-Users (Pharmaceutical and Biotechnology Companies) -Forecast to 2018
1 INTRODUCTION 20

1.1 OBJECTIVES OF THE STUDY 20
1.2 REPORT DESCRIPTION 20
1.3 MARKETS COVERED 21
1.4 STAKEHOLDERS 23
1.5 RESEARCH METHODOLOGY 24
1.5.1 SECONDARY SOURCES 24
1.5.2 PRIMARY SOURCES 25
1.5.3 MARKET SIZE ESTIMATION 25
1.5.4 MARKET SHARE 30
1.5.5 KEY DATA POINTS FROM SECONDARY SOURCES 30
1.5.6 KEY DATA POINTS FROM PRIMARY SOURCES 31
1.5.7 ASSUMPTIONS 31
1.6 MARKET SCOPE 32

2 EXECUTIVE SUMMARY 33

3 PREMIUM INSIGHTS 36

3.1 SNAPSHOT 36
3.2 MARKET SIZE 37
3.2.1 MARKET DYNAMICS 38
3.2.2 GEOGRAPHIC ANALYSIS and TECHNOLOGY 39
3.3 TECHNOLOGY MARKET 40
3.4 END-USER MARKET 41
3.5 COMPETITIVE LANDSCAPE 42

4 MARKET OVERVIEW 43

4.1 INTRODUCTION 44
4.2 EVOLUTION 45
4.3 MARKET SEGMENTATION 47
4.4 MARKET DYNAMICS 48
4.4.1 DRIVERS 48
4.4.1.1 Increasing RandD in Pharmaceutical and Biotechnological arenas propels the Protein Crystallization and Crystallography market 48
4.4.1.2 Technological innovations to spur the Protein Crystallography market 49
4.4.1.3 Availability of government funding increases research activities 49
4.4.1.4 Growing and immediate need for high-resolution structure information on membrane proteins to spur the market growth 50
4.4.1.5 Enormous increments in the number of protein structures deposited in the Protein Data Bank (PDB) to drive the Protein Crystallization and Crystallography market 50
4.4.1.6 Increasing public-private partnerships present significant opportunities 51
4.4.2 RESTRAINTS 52
4.4.2.1 Exorbitant consumption of time and cost to inhibit growth 52
4.4.2.2 Reduction in RandD budget to restrict growth 52
4.4.2.3 Need for well-qualified researchers and mandatory training increases cost 53
4.4.2.4 Methods of crystallization are specific to the type of proteins, which acts as a major challenge 53
4.4.3 OPPORTUNITIES 54
4.4.3.1 The growing need to identify new ligands for the drug discovery process creates growth opportunities for the Protein Crystallography market 54
4.4.3.2 Rising popularity of structure-based/rational drug design to propel growth 54
4.4.4 THREATS 55
4.4.4.1 Alternate technology like colloidal crystallization to limit the growth of the Protein Crystallography market 55
4.5 TRENDS and TECHNOLOGY 56
4.5.1 X-RAY-FREE ELECTRON LASERS WITH ENHANCED FUNCTIONS 56
4.5.2 LAB AUTOMATION FOR INCREASED EFFICIENCY and ACCURATE CRYSTALLIZATION and CRYSTALLOGRAPHY 56
4.6 MARKET SHARE ANALYSIS 57

5 PROTEIN CRYSTALLIZATION and CRYSTALLOGRAPHY MARKET, BY TECHNOLOGY 60

5.1 INTRODUCTION 61
5.2 PROTEIN PURIFICATION SYSTEMS 61
5.2.1 CHROMATOGRAPHY 66
5.2.1.1 Affinity chromatography 68
5.2.1.1.1 Affinity chromatography has high specificity, hence largely used in protein science 68
5.2.1.2 Ion-exchange chromatography 70
5.2.1.3 Gel-filtration chromatography 71
5.2.1.4 High Pressure Liquid Chromatography (HPLC) 72
5.2.2 ELECTROPHORESIS 73
5.2.2.1 Gel electrophoresis 74
5.2.2.1.1 2D electrophoresis market has high growth potential 74
5.2.2.2 Capillary electrophoresis 76
5.2.2.3 Others 77
5.3 PROTEIN CRYSTALLIZATION 78
5.3.1 PROTEIN CRYSTALLIZATION OCCUPIES THE LARGEST SHARE 78
5.3.2 INSTRUMENTS 81
5.3.2.1 Liquid-handling systems and robots 83
5.3.2.2 Crystallization plates/microplates 85
5.3.2.3 Others (Dialysis buttons, incubators, cooling crystallizers, and other instruments) 86
5.3.3 REAGENTS/CONSUMABLES 87
5.3.3.1 Protein structure determination studies on a rise, thus propelling the reagents market 87
5.3.3.2 Crystallization screens 89
5.3.3.3 Others (Salts, alcohols, buffers and additives) 91
5.4 PROTEIN CRYSTAL MOUNTING 92
5.5 PROTEIN CRYSTALLOGRAPHY 96
5.5.1 BY TECHNOLOGY 99
5.5.1.1 X-Ray crystallography 100
5.5.1.1.1 X-ray crystallography is the most commonly used technology 100
5.5.1.2 NMR spectroscopy 102
5.5.1.3 Cryo-electron microscopy 103
5.5.1.4 Others (SAXS) 104
5.5.2 BY PRODUCT 105
5.5.2.1 Instruments 106
5.5.2.2 Services and software 107

6 PROTEIN CYSTALLIZATION and CRYSTALLOGRAPHY MARKET, BY PRODUCT 109

6.1 INTRODUCTION 110
6.2 INSTRUMENTS 111
6.3 REAGENTS/CONSUMABLES 114
6.3.1 REAGENTS ACCOUNT FOR THE LARGEST SHARE OF MORE THAN 50% 114
6.4 SERVICES and SOFTWARE 116
6.4.1 SERVICES and SOFTWARE MARKET TO GROW AT A DECENT PACE ALONG WITH INSTRUMENTS and REAGENTS 116

7 PROTEIN CRYSTALLIZATION and CRYSTALLOGRAPHY MARKET, BY END USERS 118

7.1 INTRODUCTION 119
7.1.1 PHARMACEUTICAL COMPANIES TO GROW THE FASTEST 119
7.2 PHARMACEUTICAL COMPANIES 121
7.2.1 RISING COST OF DRUG DEVELOPMENT AND DECREASE IN THE NUMBER OF NCES TO DRIVE PHARMACEUTICAL MARKET 121
7.3 BIOTECHNOLOGY COMPANIES 123
7.3.1 INCREASING APPLICATIONS OF CRYSTALLOGRAPHY TO DRIVE THE BIOTECHNOLOGY SEGMENT 123
7.4 GOVERNMENT INSTITUTES 125
7.4.1 GOVERNMENT-FUNDED RESEARCH PROJECTS TO BOOST THE END USER MARKET 125
7.5 ACADEMIC INSTITUTIONS 127

8 GEOGRAPHIC ANALYSIS 128

8.1 INTRODUCTION 129
8.1.1 ASIA PRESENTS HUGE GROWTH OPPORTUNITIES 129
8.2 NORTH AMERICA 133
8.2.1 STRUCTURE-BASED DRUG DESIGNING BY PHARMACEUTICAL COMPANIES DRIVES THE NORTH AMERICAN MARKET 133
8.2.2 AVAILABILITY OF FUNDS FROM THE GOVERNMENT TO DRIVE THE NORTH AMERICAN MARKET 134
8.3 EUROPE 138
8.3.1 GROWING RESEARCH and APPLICATIONS OF PROTEIN CRYSTALLOGRAPHY TO STEADY THE EUROPEAN ECONOMY 138
8.4 ASIA 143
8.4.1 CHINA WILL BE THE FASTEST GROWING MARKET FOR PROTEIN CRYSTALLIZATION and CRYSTALLOGRAPHY 144
8.4.2 INCREASING RESEARCH ACTIVITIES IN INDIA TO BOOST THE MARKET 144
8.5 REST OF THE WORLD 149

9 COMPETITIVE LANDSCAPE 153

9.1 INTRODUCTION 153
9.1.1 NEW PRODUCT LAUNCH IS THE KEY STRATEGY ADOPTED BY PLAYERS 153
9.2 NEW PRODUCT LAUNCHES 155
9.3 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, and JOINT VENTURES 157
9.4 MERGERS and ACQUISITIONS 159
9.5 OTHER DEVELOPMENTS 160

10 COMPANY PROFILES 163 (Overview, Financials, Products and Services, Strategy, and Developments)*

10.1 AGILENT TECHNOLOGIES 163
10.2 ANTON PAAR 169
10.3 BRUKER CORPORATION 172
10.4 DANAHER CORPORATION 178
10.5 GE HEALTHCARE LIFE SCIENCES 182
10.6 HAMPTON RESEARCH 187
10.7 JENA BIOSCIENCE 191
10.8 LIFE TECHNOLOGIES CORPORATION 197
10.9 MITEGEN 201
10.10 MOLECULAR DIMENSIONS 210
10.11 PERKINELMER, INC 213
10.12 QIAGEN 217
10.13 RIGAKU CORPORATION 220
10.14 THERMO FISHER SCIENTIFIC 226
10.15 TECAN 232
10.16 OTHERS 234
*Details on Financials, Product and Services, Strategy, and Developments might not be captured in case of unlisted companies.
APPENDIX 238

LIST OF TABLES

TABLE 1 GLOBAL PROTEIN CRYSTALLIZATION and CRYSTALLOGRAPHY MARKET,
BY TECHNOLOGY, 2011-2018 ($MILLION) 35
TABLE 2 PROTEIN PURIFICATION MARKET, BY GEOGRAPHY,
2011-2018 ($MILLION) 62
TABLE 3 PROTEIN PURIFICATION MARKET, BY TECHNOLOGY,
2011-2018 ($MILLION) 63
TABLE 4 PROTEIN PURIFICATION MARKET, BY END USER,
2011-2018 ($MILLION) 64
TABLE 5 PROTEIN PURIFICATION MARKET, BY PRODUCT, 2011-2018 ($MILLION) 65
TABLE 6 PROTEIN PURIFICATION INSTRUMENTS MARKET, BY GEOGRAPHY, 2011-2018 ($MILLION) 65
TABLE 7 PROTEIN PURIFICATION REAGENTS MARKET, BY GEOGRAPHY,
2011-2018 ($MILLION) 66
TABLE 8 CHROMATOGRAPHY MARKET, BY GEOGRAPHY, 2011-2018 ($MILLION) 67
TABLE 9 CHROMATOGRAPHY MARKET, BY TYPE, 2011-2018 ($MILLION) 68
TABLE 10 AFFINITY CHROMATOGRAPHY MARKET, BY GEOGRAPHY,
2011-2018 ($MILLION) 69
TABLE 11 ION EXCHANGE CHROMATOGRAPHY MARKET, BY GEOGRAPHY,
2011-2018 ($MILLION) 70
TABLE 12 GEL-FILTRATION CHROMATOGRAPHY MARKET, BY GEOGRAPHY,
2011-2018 ($MILLION) 71
TABLE 13 HPLC MARKET, BY GEOGRAPHY, 2011-2018 ($MILLION) 72
TABLE 14 ELECTROPHORESIS MARKET, BY GEOGRAPHY, 2011-2018 ($MILLION) 73
TABLE 15 ELECTROPHORESIS MARKET, BY TYPE, 2011-2018 ($MILLION) 74
TABLE 16 GEL ELECTROPHORESIS MARKET, BY GEOGRAPHY,
2011-2018 ($MILLION) 75
TABLE 17 CAPILLARY ELECTROPHORESIS MARKET, BY GEOGRAPHY,
2011-2018 ($MILLION) 76
TABLE 18 OTHER PROTEIN PURIFICATION TECHNIQUES MARKET, BY GEOGRAPHY, 2011-2018 ($MILLION) 77
TABLE 19 PROTEIN CRYSTALLIZATION MARKET, BY GEOGRAPHY,
2011-2018 ($MILLION) 79
TABLE 20 PROTEIN CRYSTALLIZATION MARKET, BY PRODUCT,
2011-2018 ($MILLION) 80
TABLE 21 PROTEIN CRYSTALLIZATION MARKET, BY END USER,
2011-2018 ($MILLION) 81
TABLE 22 PROTEIN CRYSTALLIZATION INSTRUMENTS MARKET, BY GEOGRAPHY, 2011-2018 ($MILLION) 82
TABLE 23 PROTEIN CRYSTALLIZATION INSTRUMENTS MARKET, BY EQUIPMENT, 2011-2018 ($MILLION) 83
TABLE 24 LIQUID HANDLING SYSTEMS and ROBOTS MARKET, BY GEOGRAPHY, 2011-2018 ($MILLION) 84
TABLE 25 CRYSTALLIZATION PLATES/MICROPLATES MARKET, BY GEOGRAPHY, 2011-2018 ($MILLION) 85
TABLE 26 OTHER CRYSTALLIZATION INSTRUMENTS MARKET, BY GEOGRAPHY, 2011-2018 ($MILLION) 86
TABLE 27 PROTEIN CRYSTALLIZATION REAGENTS MARKET, BY GEOGRAPHY, 2011-2018 ($MILLION) 88
TABLE 28 PROTEIN CRYSTALLIZATION REAGENTS MARKET, BY PRODUCT,
2011-2018 ($MILLION) 89
TABLE 29 CRYSTALLIZATION SCREENS MARKET, BY GEOGRAPHY,
2011-2018 ($MILLION) 90
TABLE 30 OTHER CRYSTALLIZATION REAGENTS MARKET, BY GEOGRAPHY,
2011-2018 ($MILLION) 91
TABLE 31 PROTEIN CRYSTAL MOUNTING MARKET, BY GEOGRAPHY,
2011-2018 ($MILLION) 93
TABLE 32 PROTEIN CRYSTAL MOUNTING MARKET, BY TECHNOLOGY,
2011-2018 ($MILLION) 94
TABLE 33 PROTEIN CRYSTAL MOUNTING MARKET, BY END USER,
2011-2018 ($MILLION) 95
TABLE 34 PROTEIN CRYSTALLOGRAPHY MARKET, BY GEOGRAPHY,
2011-2018 ($MILLION) 97
TABLE 35 PROTEIN CRYSTALLOGRAPHY MARKET, BY END USER,
2011-2018 ($MILLION) 98
TABLE 36 PROTEIN CRYSTALLOGRAPHY MARKET, BY TECHNOLOGY,
2011-2018 ($MILLION) 100
TABLE 37 X-RAY CRYSTALLOGRAPHY MARKET, BY GEOGRAPHY,
2011-2018 ($MILLION) 101
TABLE 38 NMR SPECTROSCOPY MARKET, BY GEOGRAPHY, 2011-2018 ($MILLION) 102
TABLE 39 CRYO-ELECTRON MICROSCOPY MARKET, BY GEOGRAPHY,
2011-2018 ($MILLION) 104
TABLE 40 OTHERS (SAXS) MARKET, BY GEOGRAPHY, 2011-2018 ($MILLION) 105
TABLE 41 PROTEIN CRYSTALLOGRAPHY MARKET, BY PRODUCT,
2011-2018 ($MILLION) 106
TABLE 42 PROTEIN CRYSTALLOGRAPHY INSTRUMENTS MARKET, BY GEOGRAPHY, 2011-2018 ($MILLION) 107
TABLE 43 PROTEIN CRYSTALLOGRAPHY SERVICES and SOFTWARE MARKET,
BY GEOGRAPHY, 2011-2018 ($MILLION) 108
TABLE 44 PROTEIN CRYSTALLIZATION and CRYSTALLOGRAPHY MARKET,
BY PRODUCT, 2011-2018 ($MILLION) 110
TABLE 45 PROTEIN CRYSTALLIZATION and CRYSTALLOGRAPHY INSTRUMENTS MARKET, BY PRODUCT, 2011-2018 ($MILLION) 112
TABLE 46 PROTEIN PURIFICATION SYSTEMS MARKET, BY GEOGRAPHY,
2011-2018 ($MILLION) 112
TABLE 47 PROTEIN CRYSTALLIZATION and CRYSTALLOGRAPHY SYSTEMS MARKET, BY GEOGRAPHY, 2011-2018 ($MILLION) 113
TABLE 48 PROTEIN CRYSTALLIZATION and CRYSTALLOGRAPHY REAGENTS/CONSUMABLES MARKET, BY GEOGRAPHY,
2011-2018 ($MILLION) 115
TABLE 49 PROTEIN CRYSTALLIZATION and CRYSTALLOGRAPHY SERVICES
and SOFTWARE MARKET, BY GEOGRAPHY, 2011-2018 ($MILLION) 117
TABLE 50 PROTEIN CRYSTALLIZATION and CRYSTALLOGRAPHY MARKET,
BY END USERS, 2011-2018 ($MILLION) 120
TABLE 51 PHARMACEUTICAL PROTEIN CRYSTALLIZATION and CRYSTALLOGRAPHY MARKET, BY TECHNOLOGY, 2011-2018 ($MILLION) 122
TABLE 52 BIOTECHNOLOGY PROTEIN CRYSTALLIZATION and CRYSTALLOGRAPHY MARKET, BY TECHNOLOGY, 2011-2018 ($MILLION) 124
TABLE 53 GOVERNMENT INSTITUTES PROTEIN CRYSTALLIZATION and CRYSTALLOGRAPHY MARKET, BY TECHNOLOGY, 2011-2018 ($MILLION) 126
TABLE 54 ACADEMIC INSTITUTIONS PROTEIN CRYSTALLIZATION and CRYSTALLOGRAPHY MARKET, BY TECHNOLOGY, 2011-2018 ($MILLION) 127
TABLE 55 PROTEIN CRYSTALLIZATION and CRYSTALLOGRAPHY MARKET,
BY GEOGRAPHY, 2011-2018 ($MILLION) 132
TABLE 56 NORTH AMERICA: PROTEIN CRYSTALLIZATION and CRYSTALLOGRAPHY MARKET, BY TECHNOLOGY, 2011-2018 ($MILLION) 135
TABLE 57 NORTH AMERICA: PROTEIN CRYSTALLIZATION and CRYSTALLOGRAPHY MARKET, BY PRODUCT, 2011-2018 ($MILLION) 136
TABLE 58 NORTH AMERICA: PROTEIN CRYSTALLIZATION and CRYSTALLOGRAPHY MARKET, BY END USER, 2011-2018 ($MILLION) 137
TABLE 59 EUROPE: PROTEIN CRYSTALLIZATION and CRYSTALLOGRAPHY MARKET, BY TECHNOLOGY, 2011-2018 ($MILLION) 140
TABLE 60 EUROPE: PROTEIN CRYSTALLIZATION and CRYSTALLOGRAPHY MARKET, BY PRODUCT, 2011-2018 ($MILLION) 141
TABLE 61 EUROPE: PROTEIN CRYSTALLIZATION and CRYSTALLOGRAPHY MARKET, BY END USER, 2011-2018 ($MILLION) 142
TABLE 62 ASIA: PROTEIN CRYSTALLIZATION and CRYSTALLOGRAPHY MARKET,
BY TECHNOLOGY, 2011-2018 ($MILLION) 146
TABLE 63 ASIA: PROTEIN CRYSTALLIZATION and CRYSTALLOGRAPHY MARKET,
BY PRODUCT, 2011-2018 ($MILLION) 147
TABLE 64 ASIA: PROTEIN CRYSTALLIZATION and CRYSTALLOGRAPHY MARKET,
BY END USER, 2011-2018 ($MILLION) 148
TABLE 65 ROW: PROTEIN CRYSTALLIZATION and CRYSTALLOGRAPHY MARKET,
BY TECHNOLOGY, 2011-2018 ($MILLION) 150
TABLE 66 ROW: PROTEIN CRYSTALLIZATION and CRYSTALLOGRAPHY MARKET,
BY PRODUCT, 2011-2018 ($MILLION) 151
TABLE 67 ROW: PROTEIN CRYSTALLIZATION and CRYSTALLOGRAPHY MARKET,
BY END USER, 2011-2018 ($MILLION) 152
TABLE 68 NEW PRODUCT LAUNCHES (2011-2013) 155
TABLE 69 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, and JOINT VENTURES (2011-2013) 157
TABLE 70 MERGERS and ACQUISITIONS (2011-2013) 159
TABLE 71 OTHER DEVELOPMENTS (2011-2013) 161

LIST OF FIGURES

FIGURE 1 MARKET SIZE ESTIMATION METHODOLOGY FOR THE PROTEIN CRYSTALLIZATION and CRYSTALLOGRAPHY MARKET 26
FIGURE 2 MARKET SIZE ESTIMATION METHODOLOGY FOR THE PROTEIN CRYSTALLIZATION and CRYSTALLOGRAPHY MARKET 27
FIGURE 3 FORECAST MODEL 28
FIGURE 4 DATA TRIANGULATION METHODOLOGY (360O EVALUATION) 29
FIGURE 5 PROTEIN CRYSTALLIZATION and CRYSTALLOGRAPHY MARKET,
BY GEOGRAPHY (2013 VS. 2018) 34
FIGURE 6 SNAPSHOT OF PROTEIN CRYSTALLIZATION and CRYSTALLOGRAPHY MARKET, 2013 ($MILLION) 36
FIGURE 7 PROTEIN CRYSTALLIZATION and CRYSTALLOGRAPHY MARKET,
2011-2018 ($MILLION) 37
FIGURE 8 MARKET DYNAMICS 38
FIGURE 9 PROTEIN CRYSTALLIZATION and CRYSTALLOGRAPHY MARKET (GEOGRAPHIC ANALYSIS and TECHNOLOGY) 39
FIGURE 10 OPPORTUNTITY MATRIX: PROTEIN CRYSTALLIZATION and CRYSTALLOGRAPHY TECHNOLOGY MARKET 40
FIGURE 11 PROTEIN CRYSTALLIZATION and CRYSTALLOGRAPHY END USERS MARKET, 2013 VS 2018 ($MILLION) 41
FIGURE 12 MAJOR COMPANIES: GEOGRAPHIC REACH VS PRODUCT PROTFOLIO 42
FIGURE 13 EVOLUTION OF PROTEIN CRYSTALLIZATION and CRYSTALLOGRAPHY TECHNOLOGIES 46
FIGURE 14 PROTEIN CRYSTALLIZATION and CRYSTALLOGRAPHY MARKET SEGMENTATION 47
FIGURE 15 GLOBAL PROTEIN CRYSTALLIZATION and CRYSTALLOGRAPHY, MARKET SHARE ANALYSIS, BY KEY PLAYER, 2013 58
FIGURE 16 PROTEIN CRYSTALLOGRAPHY TECHNOLOGY MARKET, 2013 VS 2018 ($MILLION) 99
FIGURE 17 PROTEIN CRYSTALLIZATION and CRYSTALLOGRAPHY MARKET, BY END USERS, 2013 VS. 2018 119
FIGURE 18 OPPORTUNITY MATRIX: PROTEIN CRYSTALLIZATION and CRYSTALLOGRAPHY MARKET, BY GEOGRAPHY 129
FIGURE 19 PROTEIN CRYSTALLIZATION and CRYSTALLOGRAPHY MARKET, GEOGRAPHY GROWTH PHASES 131
FIGURE 20 KEY GROWTH STRATEGY, 2011-2013 154

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PEGylated Proteins Market by Consumables, Services, Protein Type, Application, End-User - Global Forecast to 2021

PEGylated Proteins Market by Consumables, Services, Protein Type, Application, End-User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • November 2016
  • by MarketsandMarkets

The global PEGylated proteins market is expected to USD 1,137.8 million by 2021 from USD 690.6 million in 2016, at a CAGR of 10.5% between 2016 and 2021. The growth of this market is mainly driven by increase ...

Protein Labeling Market by Product, Labeling Method, Application, & Region - Global Forecast to 2020

Protein Labeling Market by Product, Labeling Method, Application, & Region - Global Forecast to 2020

  • $ 5650
  • Industry report
  • December 2016
  • by MarketsandMarkets

The global protein labeling market is expected to reach USD 1,894.5 million by 2020 from USD 1,089.5 million in 2015, at a CAGR of 11.7% from 2015 to 2020. On the basis of products, the protein labeling ...

Remicade Biosimilar Market: By Type (Recombinant Non-Glycosylated Protein, Others), By Technology (MAb, rDNA, Others), By Service (Contract Research, CRAMS,Others), By Application (Blood Disorders, Oncology Diseases, Others), By Region-Forecast (2016-2021

Remicade Biosimilar Market: By Type (Recombinant Non-Glycosylated Protein, Others), By Technology (MAb, rDNA, Others), By Service (Contract Research, CRAMS,Others), By Application (Blood Disorders, Oncology Diseases, Others), By Region-Forecast (2016-2021

  • $ 5250
  • Industry report
  • September 2016
  • by Industry ARC

Globally, development of efficient and advance technology, higher expiration patent, rise in the awareness among people regarding remicade biosimilar, increasing government initiative across the globe, ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.